In lung cancer cells, connective tissue growth factor increases the expression of ARD‐1, which is also known as Naa10, an N‐terminal acetyltransferase that mediates the acetylation of HIF‐1α at Lys532, leading to its interaction with pVHL and subsequent degradation, thereby inhibiting tumour cell progression.196. Here, NAA10 is linked to neoplasm.